Evidence map›Paper›PMID 26218410›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2015

Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.

Brandon Aden, Allison Dunning, Bohdan Nosyk, Eve Wittenberg, Jeremy W Bray, Bruce R Schackman

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Estimating the health-related quality of life burden attributable to illicit drug use in Australian adults.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments.The European journal of health economics : HEPAC : health economics in prevention and care · 2020
    Article
  9. Article
  10. Mental and Physical Quality of Life by Age Groups in People Living With HIV.The Journal of the Association of Nurses in AIDS Care : JANAC
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Brandon AdenDepartments of *Medicine; †Healthcare Policy and Research, Weill Cornell Medical College, New York, NY; ‡British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada; §Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada; ‖Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA; and ¶Department of Economics, The University of North Carolina at Greensboro, Greensboro, NC.
Allison Dunning
Bohdan Nosyk
Eve Wittenberg
Jeremy W Bray
Bruce R Schackman
Cornell University · USAIDS Vancouver · CA

Funding

Quality of Life Outcomes in Prescription and Injection Opioid DependenceR01DA033424 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI SCHACKMAN, BRUCE R · 2012 to 2014
$1.6M
NIDA NIH HHS R01 DA033424
6 · The paper itself

Abstract

objectiveTo assess the impact of illicit drug use on health-related quality of life (health utility) among opioid-dependent HIV-infected patients.

designSecondary analyses of data from the Buprenorphine-HIV Evaluation and Support cohort of HIV-infected patients with opioid dependence in 9 US HIV clinics between 2004 and 2009. Health status [short form-12 (SF-12)], combination antiretroviral treatment (ART) status, CD4 cell count, hepatitis C virus antibody status, current drug use, and demographics were assessed at the initial visit and quarterly follow-up visits until 1 year. The SF-6D health utility scores were derived from the SF-12. Multivariate mixed-effects regression models were used to assess the impact of illicit drug use on health utility controlling for demographic, clinical, and social characteristics.

resultsHealth utility was assessed among 307 participants, 67% male, with a median age of 46 years at 1089 quarterly assessments. In multivariate analyses, illicit opioid use, nonopioid illicit drug use, not being on ART, and being on ART with poor adherence were associated with lower health utility. The observed decrement in health utility associated with illicit opioid use was larger for those on ART with good adherence (beta = -0.067; P < 0.01) or poor adherence (-0.049; P < 0.01) than for those not on ART.

conclusionsIllicit opioid and nonopioid drug use are negatively associated with health utility in patients with HIV; however, the relative effect of illicit opioid use is smaller than that of not being on ART. Postponing ART until initiation of opioid substitution therapy or abstinence may have limited benefits from the perspective of maximizing health utility.

Indexed as

Quality of LifeAdultFemaleHIV InfectionsHumansIllicit DrugsMaleMiddle AgedOpioid-Related DisordersSubstance-Related DisordersViral LoadIllicit Drugs

Identifiers

PMID26218410
PMCPMC4607646
OpenAlexW2470182411

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.